» Authors » Luis Gerardo Balcazar-Ochoa

Luis Gerardo Balcazar-Ochoa

Explore the profile of Luis Gerardo Balcazar-Ochoa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 3
Citations 10
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Balcazar-Ochoa L, Angeles-Lopez G, Chavarria A, Ramirez-Carreto R, Gonzalez-Hernandez A, Guzman-Ruiz M, et al.
Neurotherapeutics . 2025 Jan; 22(2):e00522. PMID: 39794241
Paclitaxel (PCX) based treatments, commonly used to treat breast, ovarian and lung cancers, have the highest incidence of chemotherapy-induced neuropathic pain, affecting from 38 to 94 ​% of patients. Unfortunately,...
2.
Balcazar-Ochoa L, Ventura-Martinez R, Angeles-Lopez G, Gomez-Acevedo C, Carrasco O, Sampieri-Cabrera R, et al.
Arch Med Res . 2023 Dec; 55(1):102916. PMID: 38039802
Clavulanic acid (CLAV) is a non-antibiotic β-lactam that has been used since the late 1970s as a β-lactamase inhibitor in combination with amoxicillin, another ß-lactam with antibiotic activity. Its long-observed...
3.
Coffeen U, Sotomayor-Sobrino M, Jimenez-Gonzalez A, Balcazar-Ochoa L, Hernandez-Delgado P, Fresan A, et al.
J Pain Res . 2019 May; 12:1331-1339. PMID: 31118752
Chemotherapy (CT) is one of the most commonly used pharmacological approaches in cancer treatment. However, CT induces damage to several tissues causing significant deleterious effects in cancer survivors being chemotherapy-induced...
4.
Ochoa-Aguilar A, Ventura-Martinez R, Sotomayor-Sobrino M, Jaimez R, Coffeen U, Jimenez-Gonzalez A, et al.
J Pain Res . 2018 Jun; 11:977-985. PMID: 29861639
Introduction: Ceftriaxone (CFX) and clavulanic acid (CA) are 2 β-lactam molecules widely used as antibiotics. However, several reports of their antiallodynic properties have been published in recent years. Although this...